Literature DB >> 24148083

Thermodynamic analysis of transition-state features in picomolar inhibitors of human 5'-methylthioadenosine phosphorylase.

Rong Guan1, Peter C Tyler, Gary B Evans, Vern L Schramm.   

Abstract

Human 5'-methylthioadenosine phosphorylase (MTAP) is solely responsible for 5'-methylthioadenosine (MTA) metabolism to permit S-adenosylmethionine salvage. Transition-state (TS) analogues of MTAP are in development as anticancer candidates. TS analogues of MTAP incorporate a cationic nitrogen and a protonated 9-deazaadenine leaving group, which are mimics of the ribocation transition state. MT-ImmA and MT-DADMe-ImmA are two examples of these TS analogues. Thermodynamic analysis of MTA, inhibitor, and phosphate binding reveals the cationic nitrogen to provide -2.6 and -3.6 kcal/mol binding free energy for MT-ImmA and MT-DADMe-ImmA, respectively. The protonated deazaadenine provides an additional -1.3 (MT-ImmA) to -1.7 kcal/mol (MT-DADMe-ImmA). MT-DADMe-ImmA is a better match in TS geometry than MT-ImmA and is thermodynamically favored. Binding of TS analogues to the MTAP/phosphate complex is fully entropic, in contrast to TS analogue binding to the related human purine nucleoside phosphorylase/phosphate complex, which is fully enthalpic (Guan, R., Ho, M. C., Brenowitz, M., Tyler, P. C., Evans, G. B., Almo, S. C., and Schramm, V. L. (2011) Biochemistry 50, 10408-10417). The binding thermodynamics of phosphate or TS analogues alone to MTAP are fully dominated by enthalpy. Phosphate anchored in the catalytic site forms an ion pair with the cationic TS analogue to cause stabilization of the enzyme structure in the ternary complex. The ternary-induced conformational changes convert the individual enthalpic binding energies to entropy, resulting in a presumed shift of the protein architecture toward the transition state. Formation of the ternary TS analogue complex with MTAP induces a remarkable increase in thermal stability (ΔTm 28 °C). The enthalpic, entropic, and protein-stability features of TS analogue binding to human MTAP are resolved in these studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24148083      PMCID: PMC3870587          DOI: 10.1021/bi401188w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Second generation transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase.

Authors:  Gary B Evans; Richard H Furneaux; Dirk H Lenz; Gavin F Painter; Vern L Schramm; Vipender Singh; Peter C Tyler
Journal:  J Med Chem       Date:  2005-07-14       Impact factor: 7.446

Review 2.  Trends in the biochemical pharmacology of 5'-deoxy-5'-methylthioadenosine.

Authors:  H G Williams-Ashman; J Seidenfeld; P Galletti
Journal:  Biochem Pharmacol       Date:  1982-02-01       Impact factor: 5.858

3.  Studies on phosphate-activated 5'-methylthioadenosine nucleosidase from human placenta.

Authors:  G Cacciapuoti; A Oliva; V Zappia
Journal:  Int J Biochem       Date:  1978

4.  The structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase at 1.7 A resolution provides insights into substrate binding and catalysis.

Authors:  T C Appleby; M D Erion; S E Ealick
Journal:  Structure       Date:  1999-06-15       Impact factor: 5.006

5.  Primate genome gain and loss: a bone dysplasia, muscular dystrophy, and bone cancer syndrome resulting from mutated retroviral-derived MTAP transcripts.

Authors:  Olga Camacho-Vanegas; Sandra Catalina Camacho; Jacob Till; Irene Miranda-Lorenzo; Esteban Terzo; Maria Celeste Ramirez; Vern Schramm; Grace Cordovano; Giles Watts; Sarju Mehta; Virginia Kimonis; Benjamin Hoch; Keith D Philibert; Carsten A Raabe; David F Bishop; Marc J Glucksman; John A Martignetti
Journal:  Am J Hum Genet       Date:  2012-03-29       Impact factor: 11.025

6.  Transition-state structure of human 5'-methylthioadenosine phosphorylase.

Authors:  Vipender Singh; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2006-11-15       Impact factor: 15.419

7.  One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.

Authors:  R W Miles; P C Tyler; R H Furneaux; C K Bagdassarian; V L Schramm
Journal:  Biochemistry       Date:  1998-06-16       Impact factor: 3.162

8.  Dependence of adenine production upon polyamine synthesis in cultured human lymphoblasts.

Authors:  N Kamatani; D A Carson
Journal:  Biochim Biophys Acta       Date:  1981-07-17

9.  Picomolar transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase and X-ray structure with MT-immucillin-A.

Authors:  Vipender Singh; Wuxian Shi; Gary B Evans; Peter C Tyler; Richard H Furneaux; Steven C Almo; Vern L Schramm
Journal:  Biochemistry       Date:  2004-01-13       Impact factor: 3.162

10.  Thermodynamic mapping of the inhibitor site of the aspartic protease endothiapepsin.

Authors:  J Gómez; E Freire
Journal:  J Mol Biol       Date:  1995-09-22       Impact factor: 5.469

View more
  4 in total

1.  Heat Capacity Changes for Transition-State Analogue Binding and Catalysis with Human 5'-Methylthioadenosine Phosphorylase.

Authors:  Ross S Firestone; Scott A Cameron; Jerome M Karp; Vickery L Arcus; Vern L Schramm
Journal:  ACS Chem Biol       Date:  2016-12-27       Impact factor: 5.100

2.  Uncertainty in protein-ligand binding constants: asymmetric confidence intervals versus standard errors.

Authors:  Vaida Paketurytė; Vytautas Petrauskas; Asta Zubrienė; Olga Abian; Margarida Bastos; Wen-Yih Chen; Maria João Moreno; Georg Krainer; Vaida Linkuvienė; Arthur Sedivy; Adrian Velazquez-Campoy; Mark A Williams; Daumantas Matulis
Journal:  Eur Biophys J       Date:  2021-04-10       Impact factor: 1.733

3.  Binding thermodynamics and interaction patterns of human purine nucleoside phosphorylase-inhibitor complexes from extensive free energy calculations.

Authors:  Zhe Huai; Huaiyu Yang; Zhaoxi Sun
Journal:  J Comput Aided Mol Des       Date:  2021-03-24       Impact factor: 3.686

4.  Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis.

Authors:  Elisangela Oliveira Freitas; Dirlei Nico; Marcus Vinícius Alves-Silva; Alexandre Morrot; Keith Clinch; Gary B Evans; Peter C Tyler; Vern L Schramm; Clarisa B Palatnik-de-Sousa
Journal:  PLoS Negl Trop Dis       Date:  2015-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.